InvestorsHub Logo
Followers 1
Posts 285
Boards Moderated 0
Alias Born 03/20/2014

Re: namtae post# 196668

Wednesday, 04/27/2016 6:19:48 AM

Wednesday, April 27, 2016 6:19:48 AM

Post# of 401266
Of course approval is already priced in considering clinical success. The only minor mystery with Elite is market penetration. Judging by other companies with already approved ADT, revenue would be anemic at best. Pfizer not really marketing their ADT further suggest not much money will be made in this space. Who here would buy a product known for massive addictive power from an OTC company? Eltp has no chance of going up against the likes of Pfizer. When it comes to marketing money speaks the loudest. ELTP has no chance of ever wrestling away any sizable share of the Opioid market.??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News